Lecture Notes

**Lecture Coverage:**
- Heart Failure
- Short-Term Heart Failure Drugs
- Long-Term Heart Failure Drugs

---
#### **Heart Failure**
**Definition of Heart Failure**
- Inability of Heart to pump blood effectively for body needs

**Symptoms of Heart Failure**
- ↓ Cardiac Muscle Contractility
	- ∵ Insufficient Ca<sup>2+</sup>, cAMP & O<sub>2</sub> Supply
- ↑ / ↓ Heart Rate (Arrhythmias)
- Vasoconstriction
- Swelling


#### **Short-Term Heart Failure Drugs**
- Focuses on Symptom Relief

**Digoxin**
- Na<sup>+</sup>/K<sup>+</sup>-ATPase Inhibitor

| Step | Event                                                                                  | Effect                          |
| ---- | -------------------------------------------------------------------------------------- | ------------------------------- |
| 1    | Na<sup>+</sup>/K<sup>+</sup>-ATPase Inhibition                                         | ↑ Intracellular Na<sup>+</sup>  |
| 2    | ↓ Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Activity                                    | ↑ Intracellular Ca<sup>2+</sup> |
| 3    | ↑ Ca<sup>2+</sup> → Positive <abbr Title="Heart Contractility">Inotropic</abbr> Effect | ↑ Cardiac Output                |
- Parasympathetic Activator
	- ↑ Acetylcholine from Vagal Fibres → Arrhythmias Relief

**Nitrates (Nitric Oxide)**
- [[Lecture 6.1 - (Cardiac Pharmacology) Antihypertensive Drugs#**Vasodilators**|Vasodilators]]
	- ↓ Heart Workload & O<sub>2</sub> Demand
- Used in Congestive Heart Failure

**Milrinone**
- Phosphodiesterase-3 Inhibitor

| Step | Event                                             | Effect           |
| ---- | ------------------------------------------------- | ---------------- |
| 1    | Phosphodiesterase-3 Inhibition                    | ↓ cAMP → AMP     |
| 2    | ↑ Cardiac Muscle cAMP → Positive Inotropic Effect | ↑ Cardiac Output |
| ^    | ↑ Smooth Muscle cAMP → Vasodilation               | ↓ Heart Workload |

**Diuretics**
- [[Lecture 6.1 - (Cardiac Pharmacology) Antihypertensive Drugs#**Diuretics**|Diuretics]]
	- ↓ Water Retention → ↓ Swelling


#### **Long-Term Heart Failure Drugs**
**Antihypertensive Drugs**
- Aim: ↓ Heart Workload → Easier O<sub>2</sub> Distribution
- Examples:
	- β Blockers
	- RAA Drugs
	- Aldosterone Inhibitor (Spironolactone)

**Aldosterone Inhibitor / Neprilysin Inhibitor (ARNIs)**
- Aim: ↓ Heart Workload → Easier O<sub>2</sub> Distribution
- Mechanism:

| Step | Event                                               | Effect                                                     |
| ---- | --------------------------------------------------- | ---------------------------------------------------------- |
| 1    | Neprilysin Inhibition                               | ↓ <abbr Title="Natriuretic Peptides">NP</abbr> Degradation |
| 2    | <abbr Title="↑ Sodium Excretion">Natriuresis</abbr> | ↑ Cardiac Output                                           |
| ^    | Vasodilation                                        | ↓ Heart Workload                                           |

**SGLT2 Inhibitor**
- Mechanism:

| Step | Event                                    | Effect                 |
| ---- | ---------------------------------------- | ---------------------- |
| 1    | SGLT2 Inhibition                         | ↑ Ketone Circulation   |
| 2    | ↑ Ketone Utilization by Heart for Energy | ↓ O<sub>2</sub> Demand |
| 3    | ↑ Efficiency of Energy Use               | ↓ Heart Workload       |

**Sinus Node Inhibitor**
- e.g. Ivabradine (SA HCN Channel Inhibitor)
- Mechanism:

| Step      | Event                                 | Effect                        |
| --------- | ------------------------------------- | ----------------------------- |
| 1         | HCN Channel Inhbition                 | ↓ SA Node Firing Rate         |
| <br><br>2 | ↑ Ventricle Filling Time              | ↑ SV                          |
| ^         | ↓ HR                                  | ↓ O<sub>2</sub> Demand        |
| ^         | Parasympathetic & Sympathetic Balance | Enhanced Autonomic Regulation |
